INZY insider buying & filings

INZYInozyme Pharma, Inc.

—

9 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 3 · scanned 3m ago

No price data yet — the yfinance scanner hasn't produced bars for INZY.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 3OTHERSubramanian SanjaySVP, CFO & Head of BDdirect39,701 @ $4.00$158.8K

Jul 3OTHERWinton MatthewCOOdirect21,743 @ $4.00$87.0K

Jul 3OTHERTreco Douglas ACEO & Chairmandirect43,861 @ $4.00$175.4K

Jul 3OTHERHopfner Robert LorneDirectorindirect1,571,741 @ $4.00$6.29M

Jul 3OTHERHopfner Robert LorneDirectorindirect2,923,110 @ $4.00$11.69M

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice